tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Biogen, Dayra Therapeutics enter research collaboration
PremiumThe FlyBiogen, Dayra Therapeutics enter research collaboration
4d ago
Biogen price target raised to $157 from $118 at Piper Sandler
Premium
The Fly
Biogen price target raised to $157 from $118 at Piper Sandler
7d ago
Biogen, Stoke Therapeutics announce publication of data from BUTTERFLY study
Premium
The Fly
Biogen, Stoke Therapeutics announce publication of data from BUTTERFLY study
11d ago
Biogen upgraded to Buy from Hold at Stifel
PremiumThe FlyBiogen upgraded to Buy from Hold at Stifel
22d ago
Biogen’s Hold Rating: Balancing Promising Growth with Revenue Challenges and Infrastructure Development
Premium
Ratings
Biogen’s Hold Rating: Balancing Promising Growth with Revenue Challenges and Infrastructure Development
25d ago
Biogen to highlight progress in rare kidney disease at ASN Kidney Week
Premium
The Fly
Biogen to highlight progress in rare kidney disease at ASN Kidney Week
25d ago
Biogen price target lowered to $250 from $255 at Baird
PremiumThe FlyBiogen price target lowered to $250 from $255 at Baird
28d ago
Biogen’s Balanced Risk-Reward Scenario: Hold Rating Amidst Strong Legacy Performance and Strategic Challenges
Premium
Ratings
Biogen’s Balanced Risk-Reward Scenario: Hold Rating Amidst Strong Legacy Performance and Strategic Challenges
28d ago
Biogen Inc. Reports Strong Q3 2025 Results
Premium
Company Announcements
Biogen Inc. Reports Strong Q3 2025 Results
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100